- Dosage must be sufficient, typically in the 60-80 mg range, but some patients require more. In no other branch of medicine can one imagine guidelines — much less regulations — that insist on the lowest possible dosage, even if that dosage is only marginally effective in saturating the receptors. No medicine can work unless given in adequate dosage, so low-dosage programs are self-defeating. In the United States, the General Accounting Office compared the effectiveness of methadone programs across the country; the least successful were those with the lowest doses.
- Duration of treatment must be adequate. In no other branch of medicine would effective therapy for a chronic disease be terminated after a fixed time. Imagine the outcry if physicians were forced to discontinue steroids and nonsteroidal anti-inflammatory drugs for rheumatoid arthritis, or digoxin for congestive heart failure. Yet some jurisdictions have mandated a time limit on methadone maintenance. Especially ironic is the view that when addicts are doing WELL on methadone, they should be terminated; one would think the opposite made more sense — that patients doing well on a drug should stay on that drug.
- Patients themselves are usually eager to quit methadone — not only because of the nuisance but also because societal attitudes make them feel demeaned. Staff should DISCOURAGE terminating methadone until fully satisfactory social rehabilitation has been achieved and no heroin whatsoever has been used for at least a year. However, if a patient does terminate prematurely and then relapses, the door should be left open for immediate readmission and re-induction without punitive attitudes on the part of treatment staff.
- Urine testing is essential — on site, with immediate feedback of results as an aid to the counseling process. Again, consider the treatment of other diseases. Would we treat hypertension without regularly checking the blood pressure? Or obesity without regular weighings? Especially with a patient population not famous for veracity, OBJECTIVE EVIDENCE provides the only sure milestones for measuring progress or detecting relapses.

AATOD...Follow Us 💫
National Organization Expanding Access to Quality Opioid Use Disorder Treatment Services Since 1984 #morethanmedicine #OUD

‼️WEBINAR ALERT
There’s still time to REGISTER for tomorrow’s (11/12) complimentary CJ webinar ➡️ bit.ly/49Lilez.
Expanding Access to Medication Assisted Treatment in Jails and Prisons.
▪️Moderator:
Mark W. Parrino, MPA will moderate the session as the President of the American Association for the Treatment of Opioid Dependence (AATOD).
▪️Presenters:
Paul N. Samuels
(Director/President, Legal Action Center) will provide an understanding of broad developments in this area, including court rulings.
▪️Brandi Harrison, BSW, MS, CCHP
(Project Manager, Justice Collaborations, Allegheny County Department of Human Services) will also discuss the opening of a treatment program in the Alleghny County Jail in Pennsylvania.
There will be ample time for Q&A, and this webinar will become available to the public for On-Demand viewing via the AATOD website.
6 days ago
#aatod2025 comes to an end!
Up Next: #aatod2027 - Spring 2027, Georgia.
1 month ago
#aatod2025 comes to an end!
Up Next: #aatod2027 - Spring 2027, Georgia.
1 month ago

See you this evening at the AATOD Open Board Meeting. #aatod2025 #theevolvingfieldofopioidtreatment
1 month ago

🗞️ Press Release #aatod2025
33 Workshops, 3 Plenary Sessions, Special Pre-Conference Sessions, Exhibits, Awards, Clinic Tours and More! https://prn.to/46RPQsT.
2 months ago

📆 #aatod2025 is just days away.
We are releasing a video message from our Conference Chair who is extending a warm invitation to Philadelphia and providing details about registering as an attendee or volunteer, or both.
REGISTER ➡️www.aatodconference.com.
#theevolvingfieldofopioidtreatment
2 months ago


⏰Standard Registration Discount Expires at Midnight.
Register before the deadline ➡️ aatodconference.com.
AATOD 2025 = 33 Workshops, 3 Plenary Sessions, Special Pre-Conference Sessions, Exhibits, Awards, Clinic Tours and More!
#aatod2025
#theevolvingfieldofopioidtreatment
2 months ago

AATOD is pleased to produce a webinar that will focus on the treatment provider response to the SAMHSA regulations governing Opioid Treatment Programs, which were fully implemented in October 2024.
REGISTER ➡️ bit.ly/3K8hYjM
Our presenters will provide detailed responses about how their programs and states have implemented these regulations and how patients have benefited from new opportunities.
There will be ample time for Q&A, and this webinar will become available to the public for On-Demand viewing via the AATOD website.
It is our hope that you will join us for this informative webinar, which serves as a prelude to our policy discussions, which will occur during our association’s approaching conference in Philadelphia between October 4-8, 2025.
**************
AATOD will host this event under the auspices of the Opioid Response Network (ORN) grant - SOR-TA No. 1H79TI088037-01.
2 months ago

We are delighted to share an exclusive update.
The AATOD Room Rate Discount has been extended through THIS FRIDAY, SEPTEMBER 19, 2025.
Take advantage of special conference rates starting as low as $299 per night!
Reservations remain available on a First Come, First Served basis.
Make your hotel reservation ➡️ bit.ly41ZPbE2
#aatod2025
#theevolvingfieldofopioidtreatment
2 months ago
The Evolving Field of Opioid Treatment
AATOD proudly presents the world’s premier training conference event for the treatment of Opioid Use Disorder.
Please come back soon and view our conference recap report.
#aatod2025 Conference Countdown
AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014
Contact Us
Phone
: 212-566-5555
Email
: info@aatod.org
Social Sharing
OPIOID EDUCATION
Stay Connected to AATOD










